Grant: Engage Plus Grants Program
McGill University
$12,500.00
Investigation of the prebiotic properties of collagen hydrolysates
EF 2018-19
Résumé
Genacol Canada Corporation Inc. manufactures a bovine-sourced hydrolyzed collagen supplement (Genacolr*Original Formula), which has shown efficacy in two separate clinical trials for reducing joint pain. Following*digestion, hydrolyzed collagen yields bioavailable amino acids and peptides that can lead to the*health-promoting properties of the supplement. There is presently, however, no information as to whether the*peptides can survive digestive processes in order to exert prebiotic effects on probiotic bacteria as this could be*a mechanism for the joint health benefits of the product. A research challenge is that typically studies*examining prebiotic properties of food components use fermentors without consideration of the digestive*processes of the stomach and small intestine. In the present study, digestion of the stomach and small intestine*in a dynamic simulated gut digestion model will be used to generate peptides that can be tested for their*prebiotic properties with fermentors containing probiotic bacteria. This approach is the first step towards*identifying whether the Genacol collagen hydrolysate has prebiotic properties that can be promoted and*examined as a mechanism of action for the reduction of joint pain seen with this product.
Programme
Engage Plus Grants Program
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
523219-2018
Name nom
Kubow, Stan
Department département
Dietetics and Human Nutrition, School of
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
501
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Processed food products and beverages
Area of application fr
Aliments transformés et boissons
Research subject code
6101
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food chemistry and analysis
Research subject fr
Chimie alimentaire et analyse
Partie
1
Nb partie
1
Application title
Investigation of the prebiotic properties of collagen hydrolysates
Keyword
NSERC
Application summary
Genacol Canada Corporation Inc. manufactures a bovine-sourced hydrolyzed collagen supplement (Genacolr*Original Formula), which has shown efficacy in two separate clinical trials for reducing joint pain. Following*digestion, hydrolyzed collagen yields bioavailable amino acids and peptides that can lead to the*health-promoting properties of the supplement. There is presently, however, no information as to whether the*peptides can survive digestive processes in order to exert prebiotic effects on probiotic bacteria as this could be*a mechanism for the joint health benefits of the product. A research challenge is that typically studies*examining prebiotic properties of food components use fermentors without consideration of the digestive*processes of the stomach and small intestine. In the present study, digestion of the stomach and small intestine*in a dynamic simulated gut digestion model will be used to generate peptides that can be tested for their*prebiotic properties with fermentors containing probiotic bacteria. This approach is the first step towards*identifying whether the Genacol collagen hydrolysate has prebiotic properties that can be promoted and*examined as a mechanism of action for the reduction of joint pain seen with this product.